Literature DB >> 9882336

Cloning and characterization of adeno-associated virus type 5.

J A Chiorini1, F Kim, L Yang, R M Kotin.   

Abstract

Adeno-associated virus type 5 (AAV5) is distinct from other dependovirus serotypes based on DNA hybridization and serological data. To better understand the biology of AAV5, we have cloned and sequenced its genome and generated recombinant AAV5 particles. The single-stranded DNA genome is similar in length and genetic organization to that of AAV2. The rep gene of AAV5 is 67% homologous to AAV2, with the majority of the changes occurring in the carboxyl and amino termini. This homology is much less than that observed with other reported AAV serotypes. The inverted terminal repeats (ITRs) are also unique compared to those of the other AAV serotypes. While the characteristic AAV hairpin structure and the Rep DNA binding site are retained, the consensus terminal resolution site is absent. These differences in the Rep proteins and the ITRs result in a lack of cross-complementation between AAV2 and AAV5 as measured by the production of recombinant AAV particles. Alignment of the cap open reading frame with that of the other AAV serotypes identifies both conserved and variable regions which could affect tissue tropism and particle stability. Comparison of transduction efficiencies in a variety of cells lines and a lack of inhibition by soluble heparin indicate that AAV5 may utilize a distinct mechanism of uptake compared to AAV2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882336      PMCID: PMC103955     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector.

Authors:  T J McCown; X Xiao; J Li; G R Breese; R J Samulski
Journal:  Brain Res       Date:  1996-03-25       Impact factor: 3.252

2.  Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats.

Authors:  J H Ryan; S Zolotukhin; N Muzyczka
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein.

Authors:  E Urcelay; P Ward; S M Wiener; B Safer; R M Kotin
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats.

Authors:  J A Chiorini; S M Wiener; R A Owens; S R Kyöstió; R M Kotin; B Safer
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

5.  Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein.

Authors:  J P Trempe; B J Carter
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.

Authors:  S Muramatsu; H Mizukami; N S Young; K E Brown
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

7.  High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors.

Authors:  J A Chiorini; C M Wendtner; E Urcelay; B Safer; M Hallek; R M Kotin
Journal:  Hum Gene Ther       Date:  1995-12       Impact factor: 5.695

8.  Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors.

Authors:  F K Ferrari; T Samulski; T Shenk; R J Samulski
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

9.  Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis.

Authors:  K J Fisher; G P Gao; M D Weitzman; R DeMatteo; J F Burda; J M Wilson
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  A maltose-binding protein/adeno-associated virus Rep68 fusion protein has DNA-RNA helicase and ATPase activities.

Authors:  R S Wonderling; S R Kyöstiö; R A Owens
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  103 in total

Review 1.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

2.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

3.  Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses.

Authors:  Jianming Qiu; Ramnath Nayak; Gregory E Tullis; David J Pintel
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  Adenoassociated virus vectors for genetic immunization.

Authors:  Selvarangan Ponnazhagan
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

5.  Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain.

Authors:  Mihail Y Mastakov; Kristin Baer; C Wymond Symes; Claudia B Leichtlein; Robert M Kotin; Matthew J During
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles.

Authors:  Ioannis Bossis; John A Chiorini
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 7.  Virus-based gene delivery systems.

Authors:  Cathryn Mah; Barry J Byrne; Terence R Flotte
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Cloning and characterization of a bovine adeno-associated virus.

Authors:  Michael Schmidt; Hisako Katano; Ioannis Bossis; John A Chiorini
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.

Authors:  Joseph E Rabinowitz; Dawn E Bowles; Susan M Faust; Julie G Ledford; Scott E Cunningham; R Jude Samulski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Incorporation of adeno-associated virus in a calcium phosphate coprecipitate improves gene transfer to airway epithelia in vitro and in vivo.

Authors:  R W Walters; D Duan; J F Engelhardt; M J Welsh
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.